Medicare Enrolled

Dr. Michael Maguire, D.O.

Family Medicine · Whittier, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7624 PAINTER AVE, Whittier, CA 90602
5629459333
In practice since 2006 (19 years)
NPI: 1881633063 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maguire from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maguire? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Maguire

Dr. Michael Maguire is a family medicine specialist in Whittier, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Maguire performed 961 Medicare services across 403 unique beneficiaries.

Between the years covered by Open Payments, Dr. Maguire received a total of $9,481 from 53 pharmaceutical and/or device companies across 533 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Maguire is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 24% volume in CA $9,481 industry payments

Medicare Practice Summary

Medicare Utilization ↗
961
Medicare services
Top 24% in CA for family medicine
403
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~51 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
640 $69 $120
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
105 $12 $50
Ear wax removal
A procedure to remove impacted ear wax from the ear canal.
38 $37 $95
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
38 $1 $25
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
28 $48 $95
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
23 $3 $8
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
23 $140 $300
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
23 $9 $45
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
19 $21 $30
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
13 $12 $68
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
11 $97 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,481
Total received (2018-2024)
Avg $1,354/year across 7 years
Top 4% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
533
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,481 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$919
2023
$1,224
2022
$1,372
2021
$1,511
2020
$1,211
2019
$1,390
2018
$1,854

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$105
Lundbeck LLC
$98
PFIZER INC.
$88
Novo Nordisk Inc
$69
Boehringer Ingelheim Pharmaceuticals, Inc.
$64
Lilly USA, LLC
$62
ABBVIE INC.
$60
GlaxoSmithKline, LLC.
$57
Sumitomo Pharma America, Inc.
$49
Novartis Pharmaceuticals Corporation
$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$34
Otsuka America Pharmaceutical, Inc.
$28
SHIELD THERAPEUTICS INC
$26
Eisai Inc.
$25
Xeris Pharmaceuticals, Inc.
$24
Azurity Pharmaceuticals, Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$18
Esperion Therapeutics, Inc.
$17
Acella Pharmaceuticals, LLC
$16
Janssen Pharmaceuticals, Inc
$14
Top 3 companies account for 31.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,035
Amgen Inc.
$883
Novo Nordisk Inc
$723
Lilly USA, LLC
$689
GlaxoSmithKline, LLC.
$623
Novartis Pharmaceuticals Corporation
$444
PFIZER INC.
$409
ABBVIE INC.
$365
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$306
Takeda Pharmaceuticals U.S.A., Inc.
$262
Boehringer Ingelheim Pharmaceuticals, Inc.
$255
AbbVie Inc.
$248
Allergan, Inc.
$237
SANOFI-AVENTIS U.S. LLC
$237
Astellas Pharma US Inc
$213
Merck Sharp & Dohme Corporation
$197
Radius Health, Inc.
$185
Lundbeck LLC
$178
Janssen Pharmaceuticals, Inc
$148
Otsuka America Pharmaceutical, Inc.
$140
Merck Sharp & Dohme LLC
$127
Dexcom, Inc.
$123
Avanir Pharmaceuticals, Inc.
$120
MannKind Corporation
$107
Mylan Specialty L.P.
$105
Almatica Pharma LLC
$92
E.R. Squibb & Sons, L.L.C.
$69
Abbott Laboratories
$67
Eisai Inc.
$66
Esperion Therapeutics, Inc.
$61
Biohaven Pharmaceutical Holding Company Ltd.
$59
Allergan Inc.
$57
Regeneron Healthcare Solutions, Inc.
$54
Sunovion Pharmaceuticals Inc.
$51
Sumitomo Pharma America, Inc.
$49
Biohaven Pharmaceuticals, Inc.
$48
Biogen, Inc.
$46
Bayer HealthCare Pharmaceuticals Inc.
$42
Mannkind Corporation
$34
Amarin Pharma Inc.
$34
Vertiflex, Inc.
$31
Supernus Pharmaceuticals, Inc.
$31
Neurocrine Biosciences, Inc.
$29
ARBOR PHARMACEUTICALS, INC.
$28
SHIELD THERAPEUTICS INC
$26
Bayer Healthcare Pharmaceuticals Inc.
$25
Xeris Pharmaceuticals, Inc.
$24
Azurity Pharmaceuticals, Inc.
$19
Daiichi Sankyo Inc.
$18
Sanofi Pasteur Inc.
$18
Acella Pharmaceuticals, LLC
$16
Kowa Pharmaceuticals America, Inc.
$15
Teva Pharmaceuticals USA, Inc.
$14
Top 3 companies account for 27.8% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADUHELM · AFREZZA · AIRSUPRA · AJOVY · AMYVID · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · BAQSIMI · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BRINTELLIX · BROVANA · BYDUREON · CHANTIX · CITALOPRAM · COMIRNATY · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FLUZONE HIGH-DOSE · FreeStyle Libre · GARDASIL 9 · GEMTESA · GRALISE · GVOKE HYPOPEN · INFINITY · INGREZZA · INVOKANA · JANUVIA · JARDIANCE · JYNARQUE · Kerendia · LEQVIO · LONHALA MAGNAIR · LOREEV XR · LYRICA · Leqembi · MOUNJARO · MYRBETRIQ · Movantik · Myrbetriq · NEXLETOL · NP Thyroid 60 · NUEDEXTA · NURTEC ODT · Nuedexta · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRADAXA · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · QULIPTA · RELISTOR · RELISTOR ORAL · REXULTI · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Superion ISS · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · Trintellix · Tymlos · UBRELVY · VAXNEUVANCE · VRAYLAR · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · Yupelri · ZOSTAVAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in CA.

Looking for a family medicine specialist in Whittier?
Compare family medicine physicians in the Whittier area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
4,073
Per 100K population
41.4
County median income
$87,760
Nearest hospital
PIH HEALTH HOSPITAL-WHITTIER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Maguire is a clinical cardiology specialist, with above-average Medicare volume (top 24% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Maguire experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Maguire performed 640 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maguire receive payments from pharmaceutical companies?
Yes. Dr. Maguire received a total of $9,481 from 53 companies across 533 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maguire's costs compare to other family medicine physicians in Whittier?
Dr. Maguire's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maguire) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →